NCT03971409 · Interventional trial
Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer
Overall registry status Active not recruiting
Phase 2
Conditions Invasive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IIIC Breast Cancer, Stage IV Breast Cancer, Triple-Negative Breast Carcinoma, Unresectable Breast Carcinoma
Delaware Valley sites
- Abramson Cancer Center, University of Pennsylvania · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory